Research location
Aberdeen
United Kingdom
Advertisement
Research activity in Aberdeen
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 187 trials and 188 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Aberdeen
187 linked trials · page 1 of 4A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusNCT07662213 · 2026-07-06 · 1 site observation
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesNCT07351058 · 2026-03-23 · 1 site observation
RECRUITING
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)NCT07222332 · 2026-02-05 · 1 site observation
RECRUITING
Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related CardiotoxicityNCT07070765 · 2025-12-12 · 1 site observation
RECRUITING
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseaseNCT07094516 · 2025-08-07 · 1 site observation
RECRUITING
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationNCT06952803 · 2025-08-06 · 1 site observation
RECRUITING
Sex Hormones as Regulators of the Age- and Sex-dependent Benefits of Caloric RestrictionNCT07065643 · 2025-07-09 · 1 site observation
RECRUITING
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinNCT06677060 · 2025-03-14 · 1 site observation
RECRUITING
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).NCT06646276 · 2025-02-25 · 1 site observation
RECRUITING
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 DiabetesNCT06435156 · 2025-01-28 · 1 site observation
RECRUITING
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLCNCT06627647 · 2024-11-27 · 1 site observation
RECRUITING
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)NCT06692738 · 2024-11-18 · 1 site observation
RECRUITING
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerNCT06119581 · 2023-12-21 · 1 site observation
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)NCT06126224 · 2023-08-28 · 1 site observation
RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)NCT05980949 · 2023-07-11 · 1 site observation
RECRUITING
Chemotherapy Induced Cognitive ImpairmentNCT05740787 · 2022-12-15 · 1 site observation
RECRUITING
Detecting Early Alzheimer's Using MRNCT05614310 · 2022-11-15 · 1 site observation
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)NCT05511363 · 2022-08-23 · 1 site observation
RECRUITING
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant ChemotherapyNCT04109079 · 2021-02-26 · 1 site observation
RECRUITING
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis StudyNCT04204915 · 2020-03-10 · 1 site observation
RECRUITING
Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised TrialNCT04302870 · 2020-02-27 · 1 site observation
RECRUITING
Scottish Advanced Fetal Research StudyNCT04613583 · 2016-05-01 · 1 site observation
RECRUITING
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityNCT07861100 · 2026-10-26 · 1 site observation
NOT_YET_RECRUITING
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon CancerNCT07808151 · 2026-09-30 · 1 site observation
NOT_YET_RECRUITING
Breast Tumour Size Measurement by Field Cycling ImagingNCT07492043 · 2026-04-01 · 1 site observation
NOT_YET_RECRUITING
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)NCT06843239 · 2025-02-06 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone TherapyNCT06440967 · 2024-07-31 · 1 site observation
ACTIVE_NOT_RECRUITING
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)NCT06383390 · 2024-04-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant HypertensionNCT06153693 · 2023-11-22 · 1 site observation
COMPLETED
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal AgentsNCT06120491 · 2023-11-21 · 1 site observation
ACTIVE_NOT_RECRUITING
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)NCT05952557 · 2023-10-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorNCT06065540 · 2023-09-27 · 2 site observations
COMPLETED
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationNCT05636176 · 2023-05-08 · 1 site observation
TERMINATED
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic AlterationsNCT05687266 · 2022-12-29 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast CancerNCT05587296 · 2022-10-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Black Barley Study - Barley to Support Food and Drink Innovation (RI-B7-3)NCT06673212 · 2022-07-27 · 1 site observation
COMPLETED
Multiple Sclerosis: FutureMS-2 - an Observational Cohort and Scottish Precision Medicine StudyNCT06001138 · 2021-10-07 · 1 site observation
ENROLLING_BY_INVITATION
Trial of Ondansetron as a Parkinson's HAllucinations TreatmentNCT04167813 · 2021-10-01 · 1 site observation
UNKNOWN
Impacts of Sugar-Sweetened Beverage on Body WeightNCT04723082 · 2021-09-10 · 1 site observation
COMPLETED
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)NCT04777396 · 2021-05-18 · 1 site observation
COMPLETED
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)NCT04777409 · 2021-05-18 · 1 site observation
COMPLETED
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid ArthritisNCT04871919 · 2021-05-11 · 1 site observation
ACTIVE_NOT_RECRUITING
PreOperative Endocrine Therapy for Individualised Care With AbemaciclibNCT04584853 · 2020-12-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.NCT04564742 · 2020-12-22 · 1 site observation
COMPLETED
Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative ResearchNCT04590976 · 2020-12-03 · 1 site observation
COMPLETED
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast CancerNCT04305496 · 2020-04-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the ProstateNCT04136353 · 2020-03-31 · 1 site observation
ACTIVE_NOT_RECRUITING
CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)NCT04226248 · 2020-01-02 · 1 site observation
COMPLETED
A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by SurgeryNCT04026412 · 2019-10-08 · 1 site observation
COMPLETED
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer TreatmentsNCT04056247 · 2019-10-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.